CIRCUIT COURSE: The trial is scheduled to begin on Wednesday, May 18.The goal is to identify those at highest risk for infection with the coronavirus.The trial will be conducted in a laboratory setting and in two phases.Phase 1 is expected to last for about a month.It will involve more than 20,000 participants, and the goal…